Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Harrington KM"" wg kryterium: Autor


Wyświetlanie 1-12 z 12
Tytuł:
Million Veteran Program's response to COVID-19: Survey development and preliminary findings.
Autorzy:
Whitbourne SB; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Nguyen XT; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Carle Illinois College of Medicine, University of Illinois, Champaign, IL, United States of America.
Song RJ; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America.
Lord E; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.
Lyden M; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.
Harrington KM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Psychiatry, Boston University School of Medicine, Boston, MA, United States of America.
Ward R; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; New England Geriatric Research, Education, and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, United States of America.
Li Y; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.
Brewer JVV; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.
Cho KM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Djousse L; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.; New England Geriatric Research, Education, and Clinical Center (GRECC), VA Boston Healthcare System, Boston, MA, United States of America.
Muralidhar S; Office of Research and Development, Veterans Health Administration, Washington, D.C., United States of America.
Tsao PS; VA Palo Alto Epidemiology Research and Information Center for Genomics, VA Palo Alto Health Care System, Palo Alto, CA, United States of America.; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, United States of America.
Gaziano JM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Casas JP; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA, United States of America.; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Pokaż więcej
Corporate Authors:
MVP COVID-19 Science Program
Źródło:
PloS one [PLoS One] 2022 Apr 25; Vol. 17 (4), pp. e0266381. Date of Electronic Publication: 2022 Apr 25 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
COVID-19*/epidemiology
Veterans*/psychology
Aged ; COVID-19 Testing ; Female ; Humans ; Male ; Mental Health ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Genomics of Gulf War Illness in U.S. Veterans Who Served during the 1990-1991 Persian Gulf War: Methods and Rationale for Veterans Affairs Cooperative Study #2006.
Autorzy:
Radhakrishnan K; Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD 20857, USA.; College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
Hauser ER; VA Cooperative Studies Program Epidemiology Center-Durham, Department of Veterans Affairs, Durham, NC 27705, USA.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27705, USA.
Polimanti R; Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven, CT 06516, USA.; School of Medicine, Yale University, New Haven, CT 06511, USA.
Helmer DA; Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Provenzale D; VA Cooperative Studies Program Epidemiology Center-Durham, Department of Veterans Affairs, Durham, NC 27705, USA.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27705, USA.
McNeil RB; VA Cooperative Studies Program Epidemiology Center-Durham, Department of Veterans Affairs, Durham, NC 27705, USA.
Maffucci A; Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven, CT 06516, USA.
Quaden R; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA 02130, USA.
Zhao H; Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven, CT 06516, USA.; Department of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA.
Whitbourne SB; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA 02130, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Department of Medicine, Division of Aging, Brigham and Women's Hospital, Boston, MA 02115, USA.
Harrington KM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA 02130, USA.; Department of Psychiatry, Boston University School of Medicine, Boston, MA 02118, USA.
Vahey J; VA Cooperative Studies Program Epidemiology Center-Durham, Department of Veterans Affairs, Durham, NC 27705, USA.; Computational Biology and Bioinformatics Program, Duke University, Durham, NC 27705, USA.
Gelernter J; Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven, CT 06516, USA.; School of Medicine, Yale University, New Haven, CT 06511, USA.
Levey DF; Division of Human Genetics, Department of Psychiatry, School of Medicine, Yale University, New Haven, CT 06511, USA.; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, CT 06516, USA.
Huang GD; Cooperative Studies Program, VA Office of Research and Development, Washington, DC 20420, USA.
Gaziano JM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA 02130, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Concato J; School of Medicine, Yale University, New Haven, CT 06511, USA.; Food and Drug Administration, Silver Spring, MD 20993, USA.
Aslan M; Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven, CT 06516, USA.; School of Medicine, Yale University, New Haven, CT 06511, USA.
Pokaż więcej
Źródło:
Brain sciences [Brain Sci] 2021 Jun 25; Vol. 11 (7). Date of Electronic Publication: 2021 Jun 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID).
Autorzy:
Bessesen MT; Department of Veterans Affairs Eastern Colorado Healthcare System, Denver, CO, USA.; Division of Infectious Diseases, Department of Medicine, University of Colorado - Denver, Aurora, CO, USA.
Doros G; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.; Department of Biostatistics, Boston University, Boston, MA, USA.
Henrie AM; Department of Veterans Affairs, Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Office of Research and Development, Albuquerque, NM, USA.
Harrington KM; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.; Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
Hermos JA; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Bonomo RA; Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA.; Case Western Reserve University, Cleveland, OH, USA.
Ferguson RE; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Huang GD; Department of Veterans Affairs, Cooperative Studies Program Central Office, Washington, DC, USA.
Brown ST; James J. Peters VA Medical Center, New York, NY, USA. .; Department of Medicine, Icahn School of Medicine at Mt. Sinai, New York, NY, USA. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Jan 08; Vol. 20 (1), pp. 23. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Amputation, Surgical*/statistics & numerical data
Veterans*/statistics & numerical data
Diabetic Foot/*drug therapy
Osteomyelitis/*drug therapy
Rifampin/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Antibiotic Prophylaxis ; Diabetic Foot/complications ; Diabetic Foot/epidemiology ; Diabetic Foot/surgery ; Double-Blind Method ; Female ; Foot/microbiology ; Foot/pathology ; Foot/surgery ; Humans ; Male ; Middle Aged ; Osteomyelitis/complications ; Osteomyelitis/epidemiology ; Osteomyelitis/surgery ; Placebos ; Prospective Studies ; Secondary Prevention/methods ; Young Adult
Czasopismo naukowe
Tytuł:
Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
Autorzy:
Dintzis SM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Hansen S; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Harrington KM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Tan LC; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Miller DM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Ishak L; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Parrish-Novak J; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Kittle D; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Perry J; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Gombotz C; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Fortney T; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Porenta S; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Hales L; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Calhoun KE; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Anderson BO; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Javid SH; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Byrd DR; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2019 Sep; Vol. 143 (9), pp. 1076-1083. Date of Electronic Publication: 2018 Dec 14.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Fluorescent Dyes*
Scorpion Venoms*
Breast Carcinoma In Situ/*diagnostic imaging
Breast Neoplasms/*diagnostic imaging
Carcinoma, Ductal, Breast/*diagnostic imaging
Carcinoma, Lobular/*diagnostic imaging
Indocyanine Green/*analogs & derivatives
Breast Carcinoma In Situ/pathology ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Lobular/pathology ; Carcinoma, Lobular/surgery ; Female ; Humans ; Intraoperative Care/methods ; Margins of Excision ; Mastectomy ; Mastectomy, Segmental ; Neoplasm Invasiveness/diagnostic imaging ; Neoplasm Invasiveness/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Validation of an Electronic Medical Record-Based Algorithm for Identifying Posttraumatic Stress Disorder in U.S. Veterans.
Autorzy:
Harrington KM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA.
Quaden R; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Stein MB; Psychiatry Service, VA San Diego Healthcare System, San Diego, California, USA.; Departments of Psychiatry and Family Medicine & Public Health, University of California San Diego, La Jolla, California, USA.
Honerlaw JP; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Cissell S; Psychiatry Service, VA San Diego Healthcare System, San Diego, California, USA.
Pietrzak RH; Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Zhao H; VA Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Radhakrishnan K; VA Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Aslan M; VA Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Gaziano JM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Concato J; VA Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Gagnon DR; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Gelernter J; Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA.; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.; Departments of Genetics and Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.
Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Corporate Authors:
VA Million Veteran Program and Cooperative Studies Program
Źródło:
Journal of traumatic stress [J Trauma Stress] 2019 Apr; Vol. 32 (2), pp. 226-237.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Validation Study
MeSH Terms:
Electronic Health Records*
Stress Disorders, Post-Traumatic/*diagnosis
Veterans/*psychology
Algorithms ; Female ; Genome-Wide Association Study ; Humans ; Male ; Predictive Value of Tests ; Stress Disorders, Post-Traumatic/classification ; United States ; United States Department of Veterans Affairs ; Veterans/statistics & numerical data
Czasopismo naukowe
Tytuł:
Genomics of posttraumatic stress disorder in veterans: Methods and rationale for Veterans Affairs Cooperative Study #575B.
Autorzy:
Radhakrishnan K; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Aslan M; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; School of Medicine, Yale University, New Haven, Connecticut, USA.
Harrington KM; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; School of Medicine, Boston University, Boston, Massachusetts, USA.
Pietrzak RH; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; U.S. Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven, Connecticut, USA.
Huang G; Office of Research and Development, Veterans Health Administration, Washington, DC, USA.
Muralidhar S; Office of Research and Development, Veterans Health Administration, Washington, DC, USA.
Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Quaden R; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Gagnon D; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; School of Public Health, Boston University, Boston, Massachusetts, USA.
Pyarajan S; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.
Sun N; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; School of Medicine, Yale University, New Haven, Connecticut, USA.
Zhao H; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; School of Medicine, Yale University, New Haven, Connecticut, USA.
Gaziano M; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, USA.; Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Concato J; Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System, West Haven, Connecticut, USA.; School of Medicine, Yale University, New Haven, Connecticut, USA.
Stein MB; VA San Diego Healthcare System, San Diego, California, USA.; School of Medicine, University of California, San Diego, La Jolla, California, USA.
Gelernter J; School of Medicine, Yale University, New Haven, Connecticut, USA.; Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut, USA.
Pokaż więcej
Źródło:
International journal of methods in psychiatric research [Int J Methods Psychiatr Res] 2019 Mar; Vol. 28 (1), pp. e1767. Date of Electronic Publication: 2019 Feb 14.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Stress Disorders, Post-Traumatic/*genetics
Veterans/*psychology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Algorithms ; Case-Control Studies ; Female ; Genetic Predisposition to Disease/genetics ; Genomics ; Humans ; Interviews as Topic ; Male ; Middle Aged ; Polymorphism, Single Nucleotide/genetics ; Psychiatric Status Rating Scales ; Surveys and Questionnaires ; United States ; United States Department of Veterans Affairs/statistics & numerical data ; Veterans/statistics & numerical data ; Young Adult
Czasopismo naukowe
Tytuł:
A dyadic analysis of the influence of trauma exposure and posttraumatic stress disorder severity on intimate partner aggression.
Autorzy:
Wolf EJ; National Center for PTSD at VA Boston Healthcare System, Boston, MA 02130, USA.
Harrington KM
Reardon AF
Castillo D
Taft CT
Miller MW
Pokaż więcej
Źródło:
Journal of traumatic stress [J Trauma Stress] 2013 Jun; Vol. 26 (3), pp. 329-37. Date of Electronic Publication: 2013 May 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Aggression/*psychology
Spouse Abuse/*psychology
Stress Disorders, Post-Traumatic/*psychology
Veterans/*psychology
Adult ; Aged ; Child ; Child Abuse, Sexual/psychology ; Female ; Humans ; Interpersonal Relations ; Male ; Middle Aged ; Models, Psychological ; Psychiatric Status Rating Scales ; Rape/psychology ; Severity of Illness Index ; Spouses/psychology ; Warfare ; Young Adult
Czasopismo naukowe
Tytuł:
Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.
Autorzy:
Boylan KL; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA; E-Mails: (K.L.M.B.); (B.M.); (M.S.D.); (J.D.A.); (K.M.H.); (S.E.P.).
Misemer B
De Rycke MS
Andersen JD
Harrington KM
Kalloger SE
Gilks CB
Pambuccian SE
Skubitz AP
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2011 Feb 22; Vol. 12 (2), pp. 1334-58. Date of Electronic Publication: 2011 Feb 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*metabolism
Carcinoma/*metabolism
Claudin-4/*metabolism
Ovarian Neoplasms/*metabolism
Spheroids, Cellular/*metabolism
Ascites/metabolism ; Ascites/pathology ; Biomarkers, Tumor/genetics ; Carcinoma/diagnosis ; Carcinoma/pathology ; Cell Line, Tumor ; Claudin-4/genetics ; Diagnosis, Differential ; Female ; Humans ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/pathology ; Spheroids, Cellular/pathology
Czasopismo naukowe
Tytuł:
An evaluation of competing models for the structure of PTSD symptoms using external measures of comorbidity.
Autorzy:
Miller MW; National Center for PTSD, VA Boston Healthcare System and Boston University School of Medicine, 150 South Huntington Avenue, Boston, MA 02130, USA. />Wolf EJ
Harrington KM
Brown TA
Kaloupek DG
Keane TM
Pokaż więcej
Źródło:
Journal of traumatic stress [J Trauma Stress] 2010 Oct; Vol. 23 (5), pp. 631-8.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Validation Study
MeSH Terms:
Comorbidity*
Models, Theoretical*
Stress Disorders, Post-Traumatic/*physiopathology
Adult ; Humans ; Male ; Mental Status Schedule ; Middle Aged ; Veterans/psychology ; Vietnam Conflict
Czasopismo naukowe
Tytuł:
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.
Autorzy:
Andersen JD; Department of Laboratory Medicine and Pathology, University of Minnesota, MMC 609, 420 Delaware St, SE Minneapolis, MN, USA. .
Boylan KL
Jemmerson R
Geller MA
Misemer B
Harrington KM
Weivoda S
Witthuhn BA
Argenta P
Vogel RI
Skubitz AP
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2010 Sep 10; Vol. 3, pp. 21. Date of Electronic Publication: 2010 Sep 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-12 z 12

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies